Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS

v3.21.1
SUBSEQUENT EVENTS
3 Months Ended
Mar. 31, 2021
Subsequent Events [Abstract]  
Subsequent Events [Text Block]

NOTE 15 SUBSEQUENT EVENTS

 

On April 1, 2021, ViralClear issued 40,000 shares of its common stock for vested restricted stock units.

 

On April 5, 2021, BioSig Technologies, Inc. issued 28,750 shares of its common stock for vested restricted stock units.

 

On April 9, 2021, BioSig Technologies, Inc. granted an aggregate of 90,000 options to purchase shares of its common stock to four employees. The options are exercisable at $4.38 per share for ten years with one-third vesting on the first anniversary of the date of grant, and the remaining two-thirds vesting in substantially equal quarterly installments over the following two years.

 

On April 13, 2021, BioSig Technologies, Inc. granted 25,000 options to purchase shares of its common stock to an employee. The options are exercisable at $4.42 per share for ten years with one-third vesting on the first anniversary of the date of grant, and the remaining two-thirds vesting in substantially equal quarterly installments over the following two years.

 

On April 28, 2021, BioSig Technologies, Inc. issued 30,000 shares of its common stock to a consultant for services rendered valued at $110,400.

 

On April 30, 2021, BioSig Technologies, Inc. issued an aggregate of 6,948 shares of its common stock for services.